Another study reported by Chem et al. showed the p53-independent prominent cell inhibitory effect of Berberine treatment on human NSCLC cell lines NCI-H460, A549 with wild type p53 expression, and p53-deficient NCI-H1299 cells. Here, TP53 is linked to non-small cell lung carcinoma.